Joel Isaacson & Co., LLC Amgen Inc Transaction History

Joel Isaacson & Co., LLC

$2.07 Billion
Q3 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Amgen Inc stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 6,049 shares of AMGN stock, worth $1.69 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

6,049

Previous 6,355 4.82%

Holding current value

$1.69 Million

Previous $1.99 Million 1.81%

% of portfolio

0.09%

Previous 0.1%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 23, 2024	SELL	$309.38 - $337.38 $94,670 - $103,238	-306 Reduced 4.82%	6,049 $1.95 Million
Q1 2024 Apr 29, 2024	BUY	$268.87 - $324.56 $454,659 - $548,830	1,691 Added 36.26%	6,355 $1.81 Million
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $18,666 - $21,057	73 Added 1.59%	4,664 $1.34 Million
Q2 2023 Jul 26, 2023	BUY	$214.27 - $253.37 $10,499 - $12,415	49 Added 1.08%	4,591 $1.02 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $226,704 - $255,681	1,010 Added 28.6%	4,542 $1.02 Million
Q1 2022 Apr 21, 2022	SELL	$219.27 - $242.57 $3,069 - $3,395	-14 Reduced 0.39%	3,532 $890,000
Q4 2021 Jan 19, 2022	SELL	$198.88 - $227.6 $1,193 - $1,365	-6 Reduced 0.17%	3,546 $798,000
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $2,334 - $2,735	11 Added 0.31%	3,552 $755,000
Q2 2021 Jul 20, 2021	BUY	$233.58 - $259.14 $42,978 - $47,681	184 Added 5.48%	3,541 $863,000
Q4 2020 Jan 22, 2021	SELL	$216.38 - $257.67 $28,129 - $33,497	-130 Reduced 3.73%	3,357 $772,000
Q3 2020 Oct 14, 2020	BUY	$234.65 - $260.95 $21,353 - $23,746	91 Added 2.68%	3,487 $886,000
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $9,297 - $11,408	47 Added 1.4%	3,396 $801,000
Q1 2020 Apr 21, 2020	BUY	$182.24 - $241.7 $4,738 - $6,284	26 Added 0.78%	3,349 $679,000
Q3 2019 Oct 15, 2019	SELL	$174.11 - $208.62 $2,959 - $3,546	-17 Reduced 0.51%	3,323 $643,000
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $11,168 - $13,092	-67 Reduced 1.97%	3,340 $615,000
Q1 2019 Apr 09, 2019	SELL	$180.87 - $203.88 $4,521 - $5,097	-25 Reduced 0.73%	3,407 $647,000
Q4 2018 Jan 18, 2019	BUY	$178.4 - $208.25 $19,802 - $23,115	111 Added 3.34%	3,432 $688,000
Q2 2018 Aug 01, 2018	SELL	$166.05 - $186.51 $83,025 - $93,255	-500 Reduced 13.09%	3,321 $613,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $75,057 - $87,714	443 Added 13.11%	3,821 $651,000
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $565,105 - $645,198	3,378	3,378 $630,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Account

Joel Isaacson & Co., LLC Amgen Inc Transaction History